Bayer | BAYN - Ebitda


Bayer reported EUR2.14B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Air Liquide EUR 4.22B 399.7M Jun/2026
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 795M 478M Mar/2026
Amarin USD 12.54M 28.57M Jun/2025
Arkema EUR 390.9M 108.2M Jun/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
BASF EUR 1.64B 806M Sep/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 926M 58M Jun/2026
Corteva USD 1.44B 992M Mar/2026
Covestro EUR 117M 125M Dec/2025
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 843.66M 19.66M Jun/2026
Genmab DKK 401M 186M Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Linde USD 3.16B 280M Sep/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.6B 69M Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Nutrien USD 2.43B 1.33B Jun/2026
Philips EUR 910M 343M Jun/2026
PPG Industries USD 793M 13M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
SAP EUR 3.36B 1000K Sep/2026
Solvay EUR 187M 32M Jun/2026
UCB EUR 1.6B 570M Dec/2025
Umicore EUR 577M 163M Jun/2026
Vinci EUR 6.4B 1.42B Jun/2026